JP2000080047A5 - - Google Patents

Download PDF

Info

Publication number
JP2000080047A5
JP2000080047A5 JP1999183299A JP18329999A JP2000080047A5 JP 2000080047 A5 JP2000080047 A5 JP 2000080047A5 JP 1999183299 A JP1999183299 A JP 1999183299A JP 18329999 A JP18329999 A JP 18329999A JP 2000080047 A5 JP2000080047 A5 JP 2000080047A5
Authority
JP
Japan
Prior art keywords
medicament according
appetite suppressant
insulin sensitizer
medicament
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999183299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000080047A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP11183299A priority Critical patent/JP2000080047A/ja
Priority claimed from JP11183299A external-priority patent/JP2000080047A/ja
Publication of JP2000080047A publication Critical patent/JP2000080047A/ja
Publication of JP2000080047A5 publication Critical patent/JP2000080047A5/ja
Pending legal-status Critical Current

Links

JP11183299A 1998-06-30 1999-06-29 医 薬 Pending JP2000080047A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11183299A JP2000080047A (ja) 1998-06-30 1999-06-29 医 薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18370098 1998-06-30
JP10-183700 1998-06-30
JP11183299A JP2000080047A (ja) 1998-06-30 1999-06-29 医 薬

Publications (2)

Publication Number Publication Date
JP2000080047A JP2000080047A (ja) 2000-03-21
JP2000080047A5 true JP2000080047A5 (cg-RX-API-DMAC7.html) 2006-06-22

Family

ID=26501804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11183299A Pending JP2000080047A (ja) 1998-06-30 1999-06-29 医 薬

Country Status (1)

Country Link
JP (1) JP2000080047A (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176746A1 (en) * 2002-05-17 2005-08-11 Frank Weber Use of compounds that are effective as selective opiate receptor modulators
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
ES2660170T3 (es) 2007-01-25 2018-03-21 NAIA Metabolic, Inc. Sensibilizadores a la insulina y métodos de tratamiento
CN101677997B (zh) 2007-03-30 2012-05-09 泰奥加制药公司 用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
NZ702666A (en) * 2012-05-24 2016-08-26 Verva Pharmaceuticals Ltd A method of weight reduction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process

Similar Documents

Publication Publication Date Title
EP1236719A4 (en) NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF, USE OF THESE COMPOUNDS IN MEDICINE
JP2002543065A5 (cg-RX-API-DMAC7.html)
CA2514191A1 (en) Compound inhibiting dipeptidyl peptidase iv
JP2004504388A5 (cg-RX-API-DMAC7.html)
RU2002115263A (ru) 5-членные N-гетероциклические соединения, обладающие гипогликемической и гиполипидемической активностью
JP2002517491A5 (cg-RX-API-DMAC7.html)
RU2000131183A (ru) Производные оксииминоалкановой кислоты
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
JP2011527334A5 (cg-RX-API-DMAC7.html)
JP2003501361A5 (cg-RX-API-DMAC7.html)
JP2003509349A5 (cg-RX-API-DMAC7.html)
JP2005518398A5 (cg-RX-API-DMAC7.html)
JP2005500312A5 (cg-RX-API-DMAC7.html)
JP2002534508A5 (cg-RX-API-DMAC7.html)
JP2003335752A5 (cg-RX-API-DMAC7.html)
JP2009504748A5 (cg-RX-API-DMAC7.html)
JP2006507220A5 (cg-RX-API-DMAC7.html)
RU2005135441A (ru) Соединения для лечения метаболических расстройств
UA64726C2 (uk) Спосіб запобігання розвитку діабетів за допомогою аналогів сибутраміну (варіанти) та фармацевтичний продукт для цього (варіанти)
JP2003534359A5 (cg-RX-API-DMAC7.html)
JP2002519425A5 (cg-RX-API-DMAC7.html)
JP2005517677A5 (cg-RX-API-DMAC7.html)
NO20050569L (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
JP2005529965A5 (cg-RX-API-DMAC7.html)
CA2522738A1 (en) Compounds for the treatment of metabolic disorders